NGLFINE vs WOCKPHARMA: Stock Comparison

NGL FINE CHEM vs WOCKHARDTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. NGL FINE CHEM shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NGLFINE leads 12; WOCKPHARMA leads 1 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NGLFINEWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹1,804 Cr
₹33,908 Cr
P/E RatioNGLFINE has the lower reading
30.41x
75.68x
P/B RatioNGLFINE has the lower reading
5.28x
6.27x
EPSNGLFINE has the higher reading
₹29.78
₹6.58
Book ValueContext only
₹532.9
₹325
Dividend YieldNGLFINE has the higher reading
0.07%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹1,804 Cr
P/E Ratio
NGLFINE has a lower P/E
30.41x vs 75.68x
P/B Ratio
NGLFINE has a lower P/B
5.28x vs 6.27x
EPS
NGLFINE has higher earnings per share
₹29.78 vs ₹6.58
Dividend Yield
NGLFINE has a higher dividend yield
0.07% vs 0%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 26%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 0%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
1.79% vs -39.61%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNGLFINEWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricNGLFINEWOCKPHARMA
Live Price₹2,907.5₹2,088.7
Day Change-1.13%7.08%
Volume7,10735.58 L
52-Week High₹3,602₹2,422.3
52-Week Low₹1,271₹1,086.7
Distance from 52W High-19.28%-13.77%

Valuation

MetricNGLFINEWOCKPHARMA
Market Cap₹1,804 Cr₹33,908 Cr
P/E Ratio30.41x75.68x
P/B Ratio5.28x6.27x
EPS₹29.78₹6.58
Book Value₹532.9₹325
Dividend Yield0.07%0%

Growth

MetricNGLFINEWOCKPHARMA
Revenue Growth (TTM YoY)57.2%26%
EPS Growth (TTM YoY)1,539.8%0%
Qtr Sales Growth1.79%-39.61%
Qtr Profit Growth11.83%0%

Profitability & Leverage

MetricNGLFINEWOCKPHARMA
ROE13.01%10.28%
ROCE10.54%10.37%
Net Margin9.59%3.3%
Operating Margin12.08%28.35%
Debt to Equity0.34x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNGLFINEWOCKPHARMA
Promoter Holding72.49% 0.25 pp49.08%
FII Holding0.05% 0.02 pp7.22% 0.13 pp
DII Holding0.02% 0.02 pp9.24% 1.72 pp
Public Holding27.43% 0.19 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NGL FINE CHEM and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.